Earnings Outlook For CytomX Therapeutics
Portfolio Pulse from Benzinga Insights
CytomX Therapeutics (NASDAQ:CTMX) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.19. The company's stock price often reacts more to the guidance provided than the earnings beat or miss. In the last quarter, the company beat EPS by $0.18, which was followed by a 3.55% drop in the share price. Over the last 52-week period, shares are up 2.44%.
November 06, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CytomX Therapeutics is expected to report an EPS of $-0.19 in its upcoming earnings. The company's stock price often reacts more to the guidance provided than the earnings beat or miss.
The upcoming earnings report and the guidance provided by the company could have a significant impact on the stock price of CytomX Therapeutics. However, it's uncertain whether the impact will be positive or negative as it depends on the actual earnings and the guidance provided by the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100